Prescription drugs (1 - 10 of 11 items) in Past Year
Health Care Fraud: Information on Most Common Schemes and the Likely Effect of Smart Cards
GAO-16-216: Published: Jan 22, 2016. Publicly Released: Feb 22, 2016.
Drug Safety: FDA Expedites Many Applications, But Data for Postapproval Oversight Need Improvement
GAO-16-192: Published: Dec 15, 2015. Publicly Released: Jan 14, 2016.
DOD and VA Health Care: Actions Needed to Help Ensure Appropriate Medication Continuation and Prescribing Practices
GAO-16-158: Published: Jan 5, 2016. Publicly Released: Jan 5, 2016.
Medicare Part B: Expenditures for New Drugs Concentrated among a Few Drugs, and Most Were Costly for Beneficiaries
GAO-16-12: Published: Oct 23, 2015. Publicly Released: Nov 20, 2015.
Tricare Pharmacy Pilot: Improved Monitoring Needed with Expansion of Pilot Requirements
GAO-15-768: Published: Sep 30, 2015. Publicly Released: Oct 1, 2015.
Medicare Part D: Changes Needed to Improve CMS's Recovery Audit Program Operations and Contractor Oversight
GAO-15-633: Published: Aug 14, 2015. Publicly Released: Sep 14, 2015.
Medicaid: Additional Reporting May Help CMS Oversee Prescription-Drug Fraud Controls
GAO-15-390: Published: Jul 8, 2015. Publicly Released: Aug 10, 2015.
Prescription Drugs: More DEA Information about Registrants' Controlled Substances Roles Could Improve Their Understanding and Help Ensure Access
GAO-15-471: Published: Jun 25, 2015. Publicly Released: Jul 27, 2015.
Behavioral Health: Options for Low-Income Adults to Receive Treatment in Selected States
GAO-15-449: Published: Jun 19, 2015. Publicly Released: Jul 20, 2015.
Medicare Part B Drugs: Action Needed to Reduce Financial Incentives to Prescribe 340B Drugs at Participating Hospitals
GAO-15-442: Published: Jun 5, 2015. Publicly Released: Jul 6, 2015.